Experts preview ASTRO 2026 presentations to watch, including those on SOFT Preop, PSMAgRT, radiosurgery for depression, and AI tools for patient safety.
|Articles|July 1, 1995
Oncology NEWS International
- Oncology NEWS International Vol 4 No 7
- Volume 4
- Issue 7
Health-Related Legislation
S5755, an amendment (no. 603) introduced by Sen. McConnell (R-KY), to reform the health-care liability system and improve health-care quality through establishment of quality assurance programs, was agreed to by voice vote.
Advertisement
- S5755, an amendment (no. 603) introduced by Sen. McConnell(R-KY), to reform the health-care liability system and improvehealth-care quality through establishment of quality assuranceprograms, was agreed to by voice vote.
- S5793, an amendment (no. 605) introduced by Sen. Wellstone(D-MN), to revise provisions regarding reports on medical malpracticedata and access to certain information, was tabled by voice vote.
- S5800, an amendment (no. 608) introduced by Sen. Snowe (R-ME),to limit the amount of punitive damages that may be awarded ina health-care liability action, was agreed to by voice vote.
- S5931, an amendment (no. 611) introduced by Sen. Kyl (R-AZ),to place a limitation of $500,000 on noneconomic damages thatare awarded to compensate a claimant for pain, suffering, emotionaldistress, and other related injuries, was tabled by voice vote.
- H1566, a bill to amend the Internal Revenue Code to make permanentthe credit for clinical testing expenses for certain drugs andrare diseases or conditions was introduced by Rep. Johnson (R-CT).
Articles in this issue
about 31 years ago
ODAC Recommends Accelerated FDA Approval of Ethyol for Cytoprotectionabout 31 years ago
House Panel Holds Hearing on Self-Referralabout 31 years ago
Mitoguazone Appears Promising in HIV-Associated Refractory NHLabout 31 years ago
Responses to Anti-HER2 MoAb Seenabout 31 years ago
NCI Committed to Increasing Minority Participation in Clinical Trialsabout 31 years ago
MoAb May Improve Detection of Colon And Rectal Cancerabout 31 years ago
Zeneca Files NDA for Arimidexabout 31 years ago
Cord Blood is Used as Source of Stem Cells for Pediatric Transplantationabout 31 years ago
HCFA Needs to Do More to Prevent Medicare/Medicaid Fraud and AbuseAdvertisement
Related to this article
Data from the phase 3 MK-3475A-D77 trial support the Japanese approval of subcutaneous pembrolizumab and berahyaluronidase alfa.
David R. Gandara, MD, explains what makes KRAS G12C biologically distinct from other KRAS subtypes in NSCLC immunotherapy response.
Xiuning Le, MD, PhD, weighs sevabertinib against zongertinib and trastuzumab deruxtecan in HER2-mutant non–small cell lung cancer.
A prospective, multicenter study found that a blood-based miRNA assay combined with CA19-9 improved early detection of pancreatic ductal adenocarcinoma.
Final 5-year IMCgp100-202 data show tebentafusp improved OS vs investigator’s choice in untreated HLA-A*02:01–positive metastatic uveal melanoma.
The FDA granted platform technology designation to the immunotherapeutic platform for use in HPV-positive cancers such as head and neck, cervical, and anal.
An end-of-phase 1 meeting was supported by phase 1b data showing efficacy with LYT-220 among relapsed/refractory myelodysplastic syndrome groups.
Advertisement
Advertisement
Trending on CancerNetwork
1
Lutetium Lu 177 Dotatate Biosimilar Earns Final FDA Approval in GEP-NETs
2
PANXEON Liquid Biopsy Demonstrates Potential for Detecting Early Pancreatic Cancer
3
Rusfertide Earns Category 1 NCCN Recommendation in Polycythemia Vera
4
AdenoVerse Platform Receives FDA Designation for HPV-Associated Cancers
5